← Back to Search

Procedure

Guidewire IV Catheters for Catheter Survival

N/A

Recruiting

Led By Amit Bahl, MD

Research Sponsored by William Beaumont Hospitals

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Study participants must be ≥ 18 years old with a Vascular Access Score of 4 or 5

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 30 days post discharge

Awards & highlights

Study Summary

This trial tests if an IV catheter with a built-in guide wire is better than one without it for catheter failure.

Who is the study for?

This trial is for clinicians at Corewell Health William Beaumont University Hospital who are trained in vascular access and patients over 18 with a specific Vascular Access Score. Patients must be able to give consent, have no cognitive impairments, skin issues at the IV site, or limited elbow mobility.Check my eligibility

What is being tested?

The study compares two types of intravenous catheters: one standard ultralong catheter and another with a built-in guide wire. Participants will be randomly assigned to either group to see if the guide wire improves catheter longevity without increasing complications.See study design

What are the potential side effects?

Potential side effects may include discomfort at the insertion site, infection, phlebitis (vein inflammation), or other complications related to peripheral intravenous access.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 or older with a high need for vascular access.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ first day of hospitalization

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~first day of hospitalization

This trial's timeline: 3 weeks for screening, Varies for treatment, and first day of hospitalization for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

First-stick success rate

Survival of the BBraun 6.35 centimeter 20 gauge ultralong intravenous catheter compared to the BD 5.71 cm 20 gauge ultralong intravenous catheter with guide wire

Time to insertion

Secondary outcome measures

Catheter Associated Thrombosis

Catheter Associated bloodstream infection

Cost for all vascular needs during hospitalization

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Arm 2 (5.71 cm 20 gauge Accucath)Experimental Treatment1 Intervention

Arm 2 Device: BD 5.71 cm 20 gauge Accucath, ultralong intravenous catheter with guide wire

Group II: Arm 1 (6.35cm 20 gauge ultralong intravenous catheter)Active Control1 Intervention

Arm 1 Device: B. Braun 6.35cm 20 gauge ultralong intravenous catheter

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

William Beaumont HospitalsLead Sponsor

149 Previous Clinical Trials

112,498 Total Patients Enrolled

Amit Bahl, MDPrincipal InvestigatorWilliam Beaumont Hospitals

6 Previous Clinical Trials

939 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any openings available for prospective participants in this trial?

"According to the clinicaltrials.gov website, this experiment is actively recruiting participants as of October 24th 2023. It was initially posted on December 1st of that same year."

Answered by AI

What is the total enrollment capacity for this clinical experiment?

"Affirmative. The data hosted on clinicaltrials.gov verifies that this experimental protocol, which was initially posted on December 1st 2023, is currently seeking volunteers. Specifically, 360 individuals are required at one medical site for the trial to be completed successfully."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Evaluating the Role of the Guidewire in Peripheral Intravenous Access: A Randomized Controlled Trial of Ultrasound-Guided Catheter Survival

Amit Bahl 2023. "Evaluating the Role of the Guidewire in Peripheral Intravenous Access: A Randomized Controlled Trial of Ultrasound-Guided Catheter Survival". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06107361.